Physician profile

Shanker N Dixit

Neurology (Psychiatry & Neurology) · Las Vegas, NV

NPI 1477558674

$136,625.41

in general payments reported to CMS, 2019-2025

91 companies · $10K in 2025

The $10K reported for 2025 was more than what 89% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).

See the full distribution for Neurology (Psychiatry & Neurology)

Payments by year

General and research payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$19,806.25
Food and Beverage$17,197.22
Consulting Fee$1,500.00
Travel and Lodging$220.00
Education$88.74

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $72,994.32 2021-2025 Qulipta, Ubrelvy, Botox
Allergan, INC. $18,068.24 2019-2022
Merz North America, INC. $5,096.36 2019-2020
Janssen Pharmaceuticals, INC $4,132.05 2021-2022
Lundbeck LLC $3,105.57 2020-2025 Vyepti, Rexulti
Biogen, INC. $2,998.49 2019-2025 Tysabri, Vumerity, Skyclarys
Emd Serono, INC. $2,911.12 2019-2025 Mavenclad, Mavenclad
Sk Life Science, INC. $2,872.33 2020-2025 Xcopri
Ucb, INC. $1,852.38 2019-2025 Briviact, Rystiggo, Fintepla
Medtronic, INC. $1,656.87 2021-2024 Percept PC Brainsense
Teva Pharmaceuticals USA, INC. $1,595.42 2019-2025 Austedo Xr, Austedo, Austedo Xr
Novartis Pharmaceuticals Corporation $1,451.32 2019-2025
Medtronic USA, INC. $1,405.04 2019-2020
Neurocrine Biosciences, INC. $1,154.13 2019-2025 Ingrezza, Ongentys
Acadia Pharmaceuticals INC $1,021.44 2019-2024 Nuplazid, Daybue
Show all 85 companies
CompanyGeneral paymentsYearsTop products
Genentech USA, INC. $920.80 2019-2025 Ocrevus, Enspryng, Ocrevus Zunovo
Genzyme Corporation $916.43 2019-2025
Sunovion Pharmaceuticals INC. $914.50 2019-2022
Argenx US, INC. $770.29 2022-2025 Vyvgart Hytrulo, Vyvgart
Amgen INC. $739.42 2019-2025 Aimovig, Uplizna
Alexion Pharmaceuticals, INC. $642.92 2019-2025 Ultomiris, Soliris
Eisai INC. $555.48 2019-2025
Ipsen Innovation $515.00 2023 Dysport
Mdd US Operations, LLC $504.11 2019-2024 Apokyn, Gocovri
Lilly USA, LLC $494.74 2021-2025 Kisunla, Amyvid, Emgality
Livanova USA, INC. $494.20 2019-2024 Vns Therapy Sentiva Model 1000 Generator
Acorda Therapeutics, INC $446.70 2019-2023 Inbrija
Corium, LLC $409.11 2023 Adlarity
Neurelis, INC. $404.63 2021-2024 Valtoco
Mallinckrodt Hospital Products INC. $324.34 2020-2025 Acthar
Takeda Pharmaceuticals U.S.A., INC. $283.74 2024-2025 Hyqvia
Pfizer INC. $282.04 2023-2025
Sanofi-Aventis U.S. LLC $256.20 2020-2021
Neuropace, INC. $233.42 2019-2024
Biohaven Pharmaceuticals, INC. $219.32 2021
Biohaven Pharmaceutical Holding Company LTD. $216.42 2022
Janssen Scientific Affairs, LLC $191.85 2024-2025
Amneal Pharmaceuticals LLC $190.27 2019-2025 Crexont, Rytary
Sumitomo Pharma America, INC. $151.49 2023 Aptiom
Horizon Therapeutics Plc $148.79 2022
Astrazeneca Pharmaceuticals LP $148.07 2024-2025 Wainua
E.R. Squibb & Sons, L.L.C. $127.91 2020
Ipsen Biopharmaceuticals, INC $127.51 2023-2025 Dysport
Cala Health, INC. $122.61 2022-2023 Cala Trio
Biocodex, INC. $121.66 2023 Diacomit
Revance Therapeutics, INC. $118.78 2024 Daxi
Alnylam Pharmaceuticals INC. $116.48 2023-2025 Amvuttra, Onpattro
Genentech, INC. $110.17 2021
Celgene Corporation $110.16 2023-2025 Zeposia
Tg Therapeutics, INC. $106.65 2023-2024
Banner Life Sciences, LLC $106.07 2022-2024
Janssen Biotech, INC. $101.30 2025
Adamas Pharmaceuticals, INC. $100.33 2019-2021
Mallinckrodt Enterprises LLC $99.17 2019
Otsuka America Pharmaceutical, INC. $99.13 2023-2025 Rexulti, Nuedexta
Jazz Pharmaceuticals INC. $98.10 2025
Grifols USA, LLC $93.45 2023-2025 Gamunex-C
Tersera Therapeutics LLC $86.65 2025 Quzyttir
Merz Pharmaceuticals, LLC $81.56 2021-2025 Xeomin, Ampyra, Inbrija
Assertio Therapeutics, INC. $77.05 2019-2020
Akcea Therapeutics, INC. $76.01 2019-2020
Springworks Therapeutics, INC. $74.04 2024-2025 Gomekli
Supernus Pharmaceuticals, INC. $68.13 2019-2022
Tanabe Pharma America, INC. $62.40 2021-2024
Catalyst Pharmaceuticals, INC. $58.19 2024-2025
Ani Pharmaceuticals, INC. $57.94 2025 Purified Cortrophin Gel
Upsher-Smith Laboratories LLC $56.63 2020-2023
Avadel Cns Pharmaceuticals, LLC $53.47 2025 Lumryz
Abbott Laboratories $52.56 2019-2023 Infinity
Greenwich Biosciences, INC. $52.17 2019
Glaxosmithkline, LLC. $43.86 2019-2020
Octapharma USA, INC. $32.57 2022-2024 Octagam Immune Globulin (Human)
Otto Bock Healthcare LP $29.04 2023
Ns Pharma, INC. $23.08 2025 Viltepso
C2n Diagnostics, LLC $21.55 2025 Precivityad2
Insightec,INC $21.13 2024 Exablate
Electromed, INC. $20.76 2023 Smartvest
Boston Scientific Corporation $19.96 2020
Harmony Biosciences LLC $19.39 2020
Sandoz INC. $17.44 2024
Vanda Pharmaceuticals INC. $16.90 2025 Ponvory
Arbor Pharmaceuticals, INC. $14.88 2022
Ge Healthcare $14.33 2020
Kyowa Kirin, INC. $12.71 2020
Shire North American Group INC $12.17 2019

6 companies reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$19,663.37 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Shanker N Dixit

$136,625.41

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $10K reported for 2025 was more than what 89% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).

https://glasscript.com/doctor/157757/shanker-n-dixit

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Download CSV

The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.